P38 mediates RANKL-induced NF-kB activation and osteoclastogenesis.

被引：0
|
作者：
Abbas, S [1 ]
Abu-Amer, Y [1 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO 63130 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
M279
引用
收藏
页码：S457 / S457
页数：1
相关论文
共 50 条
  • [1] Stanniocalcin 1 inhibits RANKL-induced osteoclastogenesis.
    Gu, Hanna
    Chae, Hwa Sung
    Woo, Kyung Mi
    Ryoo, Hyun-Mo
    Baek, Jeong-Hwa
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S274 - S274
  • [2] Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-κB pathway
    Tsai, Huei-Yann
    Lin, Hui-Yi
    Fong, Yi-Chin
    Wu, Jin-Bin
    Chen, Yuh-Fung
    Tsuzuki, Minoru
    Tang, Chih-Hsin
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 588 (01) : 124 - 133
  • [3] Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling
    Thummuri, Dinesh
    Jeengar, Manish Kumar
    Shrivastava, Shweta
    Nemani, Harishankar
    Ramavat, Ravindar Naik
    Chaudhari, Pradip
    Naidu, V. G. M.
    PHARMACOLOGICAL RESEARCH, 2015, 99 : 63 - 73
  • [4] Isoliquiritigenin Derivatives Inhibit RANKL-Induced Osteoclastogenesis by Regulating p38 and NF-κB Activation in RAW 264.7 Cells
    Jeong, Seongtae
    Lee, Seahyoung
    Kim, Kundo
    Lee, Yunmi
    Lee, Jiyun
    Oh, Sena
    Choi, Jung-Won
    Kim, Sang Woo
    Hwang, Ki-Chul
    Lim, Soyeon
    MOLECULES, 2020, 25 (17):
  • [5] Wnt5a enhances RANKL-induced osteoclastogenesis.
    Maeda, K.
    Kobayashi, Y.
    Mizoguchi, T.
    Nakamichi, Y.
    Yamashita, T.
    Kinugawa, S.
    Udagawa, N.
    Marumo, K.
    Takahashi, N.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S43 - S43
  • [6] RANKL-induced HMGB1 release in osteoclastogenesis.
    Zhou, Z.
    Han, J.
    Ferguson, D.
    Xie, J.
    Xi, C.
    Stern, D.
    Wang, C.
    Xiong, W.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S263 - S263
  • [7] Interleukin 19 suppresses RANKL-induced osteoclastogenesis via the inhibition of NF-KB and p38MAPK activation and c-Fos expression in RAW264.7 cells
    Tsubaki, Masanobu
    Takeda, Tomoya
    Matsuda, Takuya
    Yamamoto, Yuuta
    Higashinaka, Aki
    Yamamoto, Kasane
    Tsurushima, Katsumasa
    Ishizaka, Toshihiko
    Nishida, Shozo
    CYTOKINE, 2021, 144
  • [8] Inactivation of GSK-3β is required for RANKL-Induced osteoclastogenesis.
    Kurihara, S.
    Kudo, A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S394 - S394
  • [9] Brain-type Creatine Kinase Is Required for RANKL-induced Osteoclastogenesis.
    Wu, H.
    Chen, J.
    Wang, M.
    Chen, Y.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S402 - S402
  • [10] Activation of NF-kB/Rel and p38 in chitosan-stimulated macrophages.
    Jeon, YJ
    TOXICOLOGICAL SCIENCES, 2003, 72 : 346 - 346
12345